Xtant Medical to Present at the Canaccord Musculoskeletal Conference

b'BELGRADE, Mont., May 13, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the Canaccord Musculoskeltal Conference on Thursday, May 20, 2021, at 3:00 PM Eastern Time.\nA live webcast of the presentation will be available on the Investors section of the Company\xe2\x80\x99s website or through the conference site by using the link below.\nA replay of the webcast will be available for approximately 90 days on the Company\xe2\x80\x99s website at www.xtantmedical.com following the conclusion of the presentation.\nXtant Medical Holdings, Inc. ( www.xtantmedical.com ) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures.

Metadata

Provider:

GlobeNewswire, Inc.

Retrieved on:

Thursday, May 13, 2021

Information

Tags:

Canaccord Genuity, Spinal fusion, Trademark, Marketing, Market economics)

Geotags:

BELGRADE, MT, Us, MONT, UNITED STATES

Organisation:

XTANT MEDICAL, INC.

Summary

Key Points:

b'BELGRADE, Mont., May 13, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the Canaccord Musculoskeltal Conference on Thursday, May 20, 2021, at 3:00 PM Eastern Time.\nA live webcast of the presentation will be available on the Investors section of the Company\xe2\x80\x99s website or through the conference site by using the link below.\nA replay of the webcast will be available for approximately 90 days on the Company\xe2\x80\x99s website at www.xtantmedical.com following the conclusion of the presentation.\nXtant Medical Holdings, Inc. ( www.xtantmedical.com ) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures.
Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.\nThe symbols \xe2\x84\xa2 and \xc2\xae denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries.
All other trademarks and trade names referred to in this release are the property of their respective owners.\n'

BELGRADE, Mont., May 13, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the Canaccord Musculoskeltal Conference on Thursday, May 20, 2021, at 3:00 PM Eastern Time.

A live webcast of the presentation will be available on the Investors section of the Company’s website or through the conference site by using the link below.

Date: Thursday, May 20, 2021
Time: 3:00 PM ET
Webcast: Click Here

A replay of the webcast will be available for approximately 90 days on the Company’s website at www.xtantmedical.com following the conclusion of the presentation.

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
Lazar FINN
Ph: 212-867-1762
Email: [email protected]